PubMed Health⌕ Search

PubMed · 14729005

Does a single time function adequately describe blood glucose concentration dynamics during an OGTT?

Abstract

The Oral Glucose Tolerance Test is a commonly used test for diagnosis of Impaired Glucose Tolerance and Type 2 Diabetes Mellitus. In practice, there are two standard sample time intervals: deltat=60 min and deltat=30 min and two standard test time durations: 120 and 180 min. However, for an accurate description of blood glucose concentration dynamics, this number of samples is not enough. In the present work, test duration is considered beyond 180 min and a shorter time interval of deltat=10 min is proposed. Two main hypotheses are discussed: (a). Blood glucose concentration dynamics can be viewed as the impulse response of a "black box" system where the output is conformed by the algebraic sum of a set of exponentially damped sinusoidal functions and (b). There exists at least one endogenous excitation that acts as a counterregulatory mechanism against hypoglycemic tendencies.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Trujillo-Arriaga Héctor Miguel, Román-Ramos Rubén. 2004. Does a single time function adequately describe blood glucose concentration dynamics during an OGTT?. https://doi.org/10.1016/s0306-9877(03)00302-5

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Detection of Delta9-tetrahydrocannabinolic acid A in human urine and blood serum by LC-MS/MS.

Delta9-tetrahydrocannabinolic acid A (Delta9-THCA-A) is the precursor of Delta9-tetrahydrocannabinol (Delta9-THC) in hemp plants. During smoking, the non-psychoactive Delta9-THCA-A is converted to Delta9-THC, the main psychoactive component of marihuana and hashish. Although the decarboxylation of Delta9-THCA-A to Delta9-THC was assumed to be complete--which means that no Delta9-THCA-A should be detectable in urine and blood serum of cannabis consumers--we found Delta9-THCA-A in the urine and blood serum samples collected from police controls of drivers suspected for driving under the influence of drugs (DUID). For LC-MS/MS analysis, urine and blood serum samples were prepared by solid-phase extraction. Analysis was performed with a phenylhexyl column using gradient elution with acetonitrile. For detection of Delta9-THCA-A, the mass spectrometer (MS) (SCIEX API 365 triple-quadrupole MS with TurboIonSpray source) was operated in the multiple reaction monitoring (MRM) mode using the following transitions: m/z357 --> 313, m/z357 --> 245 and m/z357 --> 191. Delta9-THCA-A could be detected in the urine and blood serum samples of several cannabis consumers in concentrations of up to 10.8 ng/ml in urine and 14.8 ng/ml in serum. The concentration of Delta9-THCA-A was below the Delta9-THC concentration in most serum samples, resulting in molar ratios of Delta9-THCA-A/Delta9-THC of approximately 5.0-18.6%. Only in one case, where a short elapsed time between the last intake and blood sampling is assumed, the molar ratio was 18.6% in the serum. This indicates differences in elimination kinetics, which need to be investigated in detail.

Blood Chemical Analysis↗